AI vertical integration via its Vera CPU, balancing ExportAI growth against supply and financing risks. Read why NVDA stock ...

Geron has secured FDA approval for RYTELO in low- to intermediate-1 risk MDS, marking a pivotal milestone. Learn why GERN ...

Stock futures tick higher as investors watch U.S.-Iran deal headlines, PMI/ISM manufacturing data, and Treasury yields.

ILS democratizes cat bond access for retail investors but has underperformed institutional peers since inception. Find out ...

The equity risk premium has effectively vanished. While it is a signal worth heeding, it is not cause for immediate alarm, ...

SpaceX is generating significant value with the rapid expansion of its Starlink broadband service. Read more here.

Rising government bond yields in Japan and South Korea threaten to drain global liquidity, posing elevated volatility risks ...

Swedbank's premium 12x P/E is unjustified given negative 2026 AEPS growth and real estate market vulnerabilities. Find out ...

Bicycle Therapeutics trades below net cash, reflecting market skepticism on future cash burn and delayed commercialization.

X, Metropolis and TAO to speed chip design, lithography and defect inspection with vision AI—see what it means for chips now.

China’s economic recovery flashed mixed signals in May 2026, with a strong rebound in the services sector and resilient ...

The Fidelity Value Discovery Fund gained 1.32% in Q1 2026, trailing its benchmark due to tech selection. Read the full ...